Current Advances in Noninvasive Methods for the Diagnosis of Oral Squamous Cell Carcinoma: a Review

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2023 Jan 28

PMID 36707844

Authors

Shan Wang

Mao Yang

Ruiying Li

Jie Bai

Affiliations

Soon will be listed here.

Abstract

Oral squamous cell carcinoma (OSCC), one of the most common types of cancers worldwide, is diagnosed mainly through tissue biopsy. However, owing to the tumor heterogeneity and other drawbacks, such as the invasiveness of the biopsy procedure and high cost and limited usefulness of longitudinal surveillance, there has been a focus on adopting more rapid, economical, and noninvasive screening methods. Examples of these include liquid biopsy, optical detection systems, oral brush cytology, microfluidic detection, and artificial intelligence auxiliary diagnosis, which have their own strengths and weaknesses. Extensive research is being performed on various liquid biopsy biomarkers, including novel microbiome components, noncoding RNAs, extracellular vesicles, and circulating tumor DNA. The majority of these elements have demonstrated encouraging clinical outcomes in early OSCC detection. This review summarizes the screening methods for OSCC with a focus on providing new guiding strategies for the diagnosis of the disease.

Citing Articles

Enhancing Cancer Screening and Early Diagnosis in India: Overcoming Challenges and Leveraging Emerging Technologies.

Mangayarkarasi V, Durairaj E, Ramanathan V Cureus. 2025; 17(2):e78808.

PMID: 40078237 PMC: 11902917. DOI: 10.7759/cureus.78808.

The role of molecular biomarkers in the diagnosis, prognosis, and treatment stratification of oral squamous cell carcinoma: A comprehensive review.

Ravindran S, Ranganathan S, R K, J N, A S, Kannan S J Liq Biopsy. 2025; 7:100285.

PMID: 40027232 PMC: 11863969. DOI: 10.1016/j.jlb.2025.100285.

Artificial Intelligence in Oral Cancer: A Comprehensive Scoping Review of Diagnostic and Prognostic Applications.

Vinay V, Jodalli P, Chavan M, Buddhikot C, Luke A, Ingafou M Diagnostics (Basel). 2025; 15(3).

PMID: 39941210 PMC: 11816433. DOI: 10.3390/diagnostics15030280.

Integrating omics data and machine learning techniques for precision detection of oral squamous cell carcinoma: evaluating single biomarkers.

Sun Y, Cheng G, Wei D, Luo J, Liu J Front Immunol. 2024; 15:1493377.

PMID: 39691710 PMC: 11649677. DOI: 10.3389/fimmu.2024.1493377.

Evolving trends in oral cancer burden in Europe: a systematic review.

Ghanem A, Memon H, Nagy A Front Oncol. 2024; 14:1444326.

PMID: 39493458 PMC: 11527597. DOI: 10.3389/fonc.2024.1444326.

References

Koch F, Kaemmerer P, Biesterfeld S, Kunkel M, Wagner W . Effectiveness of autofluorescence to identify suspicious oral lesions--a prospective, blinded clinical trial. Clin Oral Investig. 2010; 15(6):975-82. DOI: 10.1007/s00784-010-0455-1. View

Sridharan G, Ramani P, Patankar S . Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Cancer Res Ther. 2017; 13(3):556-561. DOI: 10.4103/jcrt.JCRT_1233_16. View

Zhao H, Chu M, Huang Z, Yang X, Ran S, Hu B . Variations in oral microbiota associated with oral cancer. Sci Rep. 2017; 7(1):11773. PMC: 5603520. DOI: 10.1038/s41598-017-11779-9. View

Mojsa I, Kaczmarzyk T, Zaleska M, Stypulkowska J, Zapala-Pospiech A, Sadecki D . Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions. J Craniofac Surg. 2012; 23(2):e162-4. DOI: 10.1097/SCS.0b013e31824cdbea. View

Aro K, Kaczor-Urbanowicz K, Carreras-Presas C . Salivaomics in oral cancer. Curr Opin Otolaryngol Head Neck Surg. 2018; 27(2):91-97. DOI: 10.1097/MOO.0000000000000502. View

Paderni C, Compilato D, Carinci F, Nardi G, Rodolico V, Lo Muzio L . Direct visualization of oral-cavity tissue fluorescence as novel aid for early oral cancer diagnosis and potentially malignant disorders monitoring. Int J Immunopathol Pharmacol. 2011; 24(2 Suppl):121-8. DOI: 10.1177/03946320110240S221. View

Fujimoto J, Pitris C, Boppart S, Brezinski M . Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. Neoplasia. 2000; 2(1-2):9-25. PMC: 1531864. DOI: 10.1038/sj.neo.7900071. View

Vashisht N, Ravikiran A, Samatha Y, Rao P, Naik R, Vashisht D . Chemiluminescence and Toluidine Blue as Diagnostic Tools for Detecting Early Stages of Oral Cancer: An invivo Study. J Clin Diagn Res. 2014; 8(4):ZC35-8. PMC: 4064898. DOI: 10.7860/JCDR/2014/7746.4259. View

Velleuer E, Dietrich R, Pomjanski N, de Santana Almeida Araujo I, Silva de Araujo B, Sroka I . Diagnostic accuracy of brush biopsy-based cytology for the early detection of oral cancer and precursors in Fanconi anemia. Cancer Cytopathol. 2020; 128(6):403-413. DOI: 10.1002/cncy.22249. View

10.

. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

11.

Lousada-Fernandez F, Rapado-Gonzalez O, Lopez-Cedrun J, Lopez-Lopez R, Muinelo-Romay L, Suarez-Cunqueiro M . Liquid Biopsy in Oral Cancer. Int J Mol Sci. 2018; 19(6). PMC: 6032225. DOI: 10.3390/ijms19061704. View

12.

Chattopadhyay I, Verma M, Panda M . Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer. Technol Cancer Res Treat. 2019; 18:1533033819867354. PMC: 6676258. DOI: 10.1177/1533033819867354. View

13.

Li Y, Tao Y, Gao S, Li P, Zheng J, Zhang S . Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine. 2018; 36:209-220. PMC: 6197737. DOI: 10.1016/j.ebiom.2018.09.006. View

14.

van Ginkel J, Huibers M, Noorlag R, de Bree R, van Es R, Willems S . Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?. Pathobiology. 2016; 84(3):115-120. DOI: 10.1159/000452861. View

15.

Yamamoto N, Kawaguchi K, Fujihara H, Hasebe M, Kishi Y, Yasukawa M . Detection accuracy for epithelial dysplasia using an objective autofluorescence visualization method based on the luminance ratio. Int J Oral Sci. 2017; 9(11):e2. PMC: 5775331. DOI: 10.1038/ijos.2017.37. View

16.

Scheer M, Neugebauer J, Derman A, Fuss J, Drebber U, Zoeller J . Autofluorescence imaging of potentially malignant mucosa lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 111(5):568-77. DOI: 10.1016/j.tripleo.2010.12.010. View

17.

Chen X, Zhang X, Liu Q, Zhang J, Zhou G . Nanotechnology: a promising method for oral cancer detection and diagnosis. J Nanobiotechnology. 2018; 16(1):52. PMC: 5994839. DOI: 10.1186/s12951-018-0378-6. View

18.

H Alsarraf A, Kujan O, Farah C . The utility of oral brush cytology in the early detection of oral cancer and oral potentially malignant disorders: A systematic review. J Oral Pathol Med. 2017; 47(2):104-116. DOI: 10.1111/jop.12660. View

19.

Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam N . A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc. 2010; 141(2):151-6. DOI: 10.14219/jada.archive.2010.0132. View

20.

Betz C, Stepp H, Janda P, Arbogast S, Grevers G, Baumgartner R . A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis. Int J Cancer. 2002; 97(2):245-52. DOI: 10.1002/ijc.1596. View